Pancreatic Cancer Research

ResearcherGeorgetown University Medical CenterActive in the last 2 years

Chunling Yi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-7710-7362; OpenAlex author ID A5013543773. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
7
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 3

  1. PRMT1 promotes epigenetic reprogramming associated with acquired chemoresistance in pancreatic cancer. Last author DOI 10.1016/j.celrep.2024.114176↗
  2. Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma. Last author DOI 10.1038/onc.2016.288↗
  3. Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma. Last author DOI 10.1126/scisignal.2005049↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shigekazu Murakami · 2 shared papers, 2017–2024 · strength 0.35
  2. Chan D.K. Nguyen · 1 shared paper, 2024 · strength 0.28
  3. Rishi Surana · 1 shared paper, 2017 · strength 0.07
  4. Louis M. Weiner · 1 shared paper, 2017 · strength 0.07
  5. Weiying Zhang · 1 shared paper, 2014 · strength 0.03
  6. Eveline E. Vietsch · 1 shared paper, 2014 · strength 0.03
  7. Anton Wellstein · 1 shared paper, 2014 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.